Denali Therapeutics (DNLI) FCF/share US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| FCF/share, rub | -1.81 | -2.09 | -2.70 | -2.21 | -2.41 | -2.25 | ||
| Changes by years, y/y, % | -148% | +16% | +29% | -18% | +9% | |||
Denali Therapeutics. FCF/share, rub
Denali Therapeutics. FCF/share, changes, %
Denali Therapeutics (DNLI) FCF/share US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| FCF/share, rub | -0.80 | -0.46 | -0.61 | -0.57 | -0.72 | -2.25 | ||
| Changes by years, y/y, % | +3% | -18% | +65% | +9% | -10% | |||
| Changes by quarters, q/q, % | +53% | -42% | +32% | -7% | +26% | |||